Meanwhile, in younger adults with obesity, glucagon-like peptide-1 receptor agonists play a crucial role by improving glycaemia, promoting weight loss, and offering cardiovascular and renal protection. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.